Amplify Treatments, Testing and Advancements ETF (GERM)

NYSEARCA: GERM · IEX Real-Time Price · USD
19.25
-0.59 (-2.98%)
Jul 18, 2024, 12:00 AM EDT - Market open
-2.98%
Assets $9.86M
Expense Ratio 0.68%
PE Ratio 7.49
Shares Out 500,000
Dividend (ttm) $0.24
Dividend Yield 1.23%
Ex-Dividend Date Jun 27, 2024
Payout Ratio 9.20%
1-Year Return n/a
Volume 55
Open 19.20
Previous Close 19.84
Day's Range 19.20 - 19.27
52-Week Low 15.67
52-Week High 21.10
Beta 0.72
Holdings 57
Inception Date Jun 17, 2020

About GERM

Fund Home Page

The Amplify Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a tier-weighted index of US-listed healthcare companies engaged in treatments, testing, and other medical advancements. Holdings are selected by the index committee GERM was launched on Jun 17, 2020 and is issued by Amplify Investments.

Asset Class Equity
Category Health
Region North America
Stock Exchange NYSEARCA
Ticker Symbol GERM
Index Tracked Prime Treatments, Testing and Advancements Index

Top 10 Holdings

52.79% of assets
Name Symbol Weight
Alnylam Pharmaceuticals, Inc. ALNY 9.63%
Labcorp Holdings Inc. LH 6.52%
Quest Diagnostics Incorporated DGX 6.24%
BioNTech SE BNTX 5.09%
Moderna, Inc. MRNA 4.81%
Vaxcyte, Inc. PCVX 4.48%
Bio-Rad Laboratories, Inc. BIO 4.41%
ImmunityBio, Inc. IBRX 4.02%
Zai Lab Limited ZLAB 3.94%
Immunocore Holdings plc IMCR 3.65%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Jun 27, 2024 $0.08799 Jun 28, 2024
Mar 26, 2024 $0.05578 Mar 28, 2024
Dec 27, 2023 $0.0522 Dec 29, 2023
Sep 20, 2023 $0.040 Sep 22, 2023
Jun 21, 2023 $0.060 Jun 23, 2023
Mar 22, 2023 $0.090 Mar 24, 2023
Full Dividend History

News

Amplify ETFs Declares June Income Distributions for its ETFs

CHICAGO, June 27, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces June income distributions for its ETFs. ETF Name Ticker   Amount per Share Ex-Date Record Date Payable Date Amplify AI Powered Equity ...

22 days ago - GlobeNewsWire

Finding Opportunity in Unloved Healthcare ETFs

Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?

7 weeks ago - ETF Trends

Amplify ETFs Completes Acquisition to Reach $9.1 Billion AUM Across 31 ETFs

CHICAGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announced today it has completed its previously announced acquisition of ETF Managers Group (ETFMG) exchange-traded fund (ETF) assets, which con...

6 months ago - GlobeNewsWire

China ETFs Drop On Audit Enforcement

The first tranche of Chinese ADRs affected by a 2020 law has been released.

Other symbols: CHIQMCHIXITK
2 years ago - ETFcom

COVID Biotech ETFs Rise At Fever Pace

ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.

Other symbols: IBBVIRSXBI
3 years ago - ETFcom

Biotech ETFs extend January gains

Biotech exchange-traded funds rallied Monday as investors continued to monitor the sector and its impact on the coronavirus pandemic. The ETFMG Treatments Testing and Advancement ETF gained 4.6% mid-m...

Other symbols: CNCRXBI
3 years ago - Market Watch

First Vaccine ETF Should See Halcyon Days Ahead

There was big news on the coronavirus vaccine front Monday when Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) said their vaccine delivered an impressive showing in Phase 3 trials. What Happened: Alon...

4 years ago - Benzinga

Investing in coronavirus themed ETFs which focus on companies involved in testing and treatment

ETF Managers Group CEO Sam Masucci discusses GERM an ETF that invests in companies that are focused on COVID-19 treatment and testing.

4 years ago - Yahoo Finance

6 Best Biotech ETFs to Buy for Cutting-Edge Growth

Biotech ETFs are, in a word, hot.

Other symbols: BTECCNCRIBBPBEXBI
4 years ago - Kiplinger

ETF Open To Close Ratio Jumps

An unusually high number of launches in June boosted the open-to-close ratio. 

Other symbols: BETZWFH
4 years ago - ETFcom

Novavax's 30% surge boosts biotech ETFs to best day in weeks

Exchange-traded funds with exposure to biotech stocks rocketed higher Tuesday on hopeful news about treatments for COVID-19.

Other symbols: NVAXBBC
4 years ago - Market Watch

New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases—but Not Covid-19

The newest health care exchange-traded fund is unique in that three stalwarts of other industry funds aren’t even among its top holdings.

4 years ago - GuruFocus